AoAF proliferation was demonstrated in vivo using CCR2 +/+ wild-type monocyte adoptive transfer into Ang II-stimulated CCR2-null mice which can produce MCP-1 but have cells lacking the MCP-1 receptor -CCR2. Results: AoAF constitutively secreted numerous proinflammatory cytokines, particularly IL-6 and MCP-1, whose gene expressions were further upregulated in response to Ang II stimulation. AoAF-derived MCP-1 was potent in recruiting THP-1 monocytes in vitro, and these monocytes stimulated AoAF proliferation based on a flow cytometric assessment of cell number and 3 H-thymidine incorporation in tissue culture. In vivo, Ang II induced fibroblast proliferation, increased fibroblast and PCNA adventitial staining, and blunted inflammatory responses in the CCR2 -/-background. Injection of CCR2 +/+ monocytes into Ang II-treated CCR2 -/-mice restored adventitial thickening which resulted in increased fibrosis secondary to adventitial fibroblast proliferation. Conclusions: Our results suggest that Ang II-stimulates AoAF to recruit monocytes via fibroblast-derived MCP-1, and the recruited monocytes further activate fibroblast proliferation, adventitial thickening, and additional cytokine production. This fibroblast-monocyte amplification loop may critically mediate hallmarks of adventitial inflammation common to many cardiovascular diseases.
AoAF proliferation was demonstrated in vivo using CCR2 +/+ wild-type monocyte adoptive transfer into Ang II-stimulated CCR2-null mice which can produce MCP-1 but have cells lacking the MCP-1 receptor -CCR2. Results: AoAF constitutively secreted numerous proinflammatory cytokines, particularly IL-6 and MCP-1, whose gene expressions were further upregulated in response to Ang II stimulation. AoAF-derived MCP-1 was potent in recruiting THP-1 monocytes in vitro, and these monocytes stimulated AoAF proliferation based on a flow cytometric assessment of cell number and 3 H-thymidine incorporation in tissue culture. In vivo, Ang II induced fibroblast proliferation, increased fibroblast and PCNA adventitial staining, and blunted inflammatory responses in the CCR2 -/-background. Injection of CCR2 +/+ monocytes into Ang II-treated CCR2 -/-mice restored adventitial thickening which resulted in increased fibrosis secondary to adventitial fibroblast proliferation. Conclusions: Our results suggest that Ang II-stimulates AoAF to recruit monocytes via fibroblast-derived MCP-1, and the recruited monocytes further activate fibroblast proliferation, adventitial thickening, and additional cytokine production. This fibroblast-monocyte amplification loop may critically mediate hallmarks of adventitial inflammation common to many cardiovascular diseases.
Introduction
Little is known about the contribution of adventitial fibroblasts to vascular wall inflammation. Their ability to produce collagen and reactive oxygen species (ROS) via NAD(P)H oxidase has been demonstrated [1, 2] ; moreover, in these cells, ROS mediate cell proliferation and differentiation to myofibroblasts [3] , which are thought to be major contributors to neointimal thickening after severe endoluminal vascular injury [4] [5] [6] . In addition to ROS production, activated fibroblasts assume a secretory phenotype responsible for cytokine secretion. Interleukin-6 (IL-6) is predominantly expressed in the adventitia of LDLR -/-mice infused with angiotensin II (Ang II) [7] , and the chemokine MCP-1 has been detected there preceding its expression in the intima following the recruitment of cells expressing CCR2, the receptor for MCP-1, to the vessel wall [8, 9] . IL-6 is known to be involved in monocyte activation and MCP-1 functions as a monocyte chemoattractant, so that they work in complementary ways in the coordination of leukocyte recruitment and activation in tissues. Importantly, approaches used in previous studies have not allowed definitive identification of the cell type(s) in the vessel wall responsible for producing these cytokines and chemokines or their functional roles. Knowledge of the spectrum of cytokines and chemokines produced by adventitial fibroblasts and the role of Ang II in upregulating their expression will be valuable in understanding the role of fibroblasts in adventitial inflammation.
Vascular wall inflammation has been observed in many cardiovascular diseases [10] and involves the cellular infiltration of lymphocytes, plasma cells, macrophages, eosinophils, and mast cells into the adventitial layer of the vessel wall [11] [12] [13] [14] . Extensive cellular infiltration into the adventitia is highly correlated with advanced atherosclerotic plaque disruption, which augments the risk of mortality [15] [16] [17] , while the expression of inflammatory cytokines in the adventitia is strongly correlated with advanced atherosclerosis [18] . Increased adventitial fibrosis also has been observed in atherosclerosis, mechanical injuries from angioplasty, and abdominal aortic aneurysms [19] . A variant of abdominal aortic aneurysms, inflammatory aortic aneurysm, has extensive adventitial infiltration of macrophages and pronounced thickening of the adventitia, which has been attributed to proliferation of adventitial myofibroblasts [20] . Whether cytokines and chemokines produced by adventitial fibroblasts can recruit leukocytes and how their recruitment affects fibroblast proliferation remains unknown.
Ang II is well known to play an important role in cardiovascular diseases such as atherosclerosis and aortic aneurysms and dissection. In vivo and in vitro, it can induce important markers of vascular inflammation, but its effects on the adventitial fibroblasts are not well known. Our focus was on IL-6 and MCP-1 since we report that human aortic adventitial fibroblasts (AoAF) in tissue culture produced these in relatively greater abundance than numerous other cytokines and chemokines. Using a combination of tissue culture and in vivo animal studies, we report that AoAF contribute significantly to vascular inflammation by producing IL-6 and MCP-1. We demonstrate that the MCP-1 produced by adventitial fibroblasts can recruit monocytes, which, in turn, promotes AoAF proliferation in vitro and in vivo. In addition, we show that Ang II potently induces the expression of IL-6 and MCP-1.
Methods

Cell Culture
Primary cultures of human AoAF (catalog No. CC-7014; Cambrex-Lonza, Walkersville, Md., USA) were purchased, grown in stromal cell growth medium (SCGM) containing 5% FBS, and used from passages 4 to 9. These cells were obtained from normal aortic tissue and their identity and purity were confirmed based on morphology, growth characteristics, and negative immunofluorescent staining for smooth muscle ␣ -actin. THP-1 cells, i.e. human leukemic promonocytic cells, were obtained from ATCC (Manassas, Va., USA) and cultured in RPMI 1640 medium containing 10% FBS. Coculture experiments were performed with 50 ! 10 3 AoAF and 200 ! 10 3 THP-1 monocytes in SCGM.
Cell Production of Cytokines and Chemokines
To determine the constitutive production and secretion of cytokines and chemokines, 50 ! 10 3 AoAF and 200 ! 10 3 THP-1 monocytic cells were grown in 1 ml of their respective media for 36 h. Twenty-five-microliter samples of fibroblast-or monocyteconditioned medium were assayed in duplicate using BioSource Multiplex kits (Invitrogen, Carlsbad, Calif., USA), and standard curves assayed in parallel were used to determine cytokine concentrations. Data were expressed as means 8 standard deviation (SD) for 6 individual samples for each cell type.
Monocyte Migration Assay
The migration of THP-1 monocytic cells to AoAF-conditioned medium was assessed using Transwell polycarbonate membrane inserts with 8-m pores (Corning Lifesciences, Lowell, Mass., USA). Briefly, 2 ! 10 6 THP-1 cells in 100 l of serumfree SCGM were placed above the inserts, and 600 l of AoAFconditioned medium or SCGM was placed below. After 2 h of incubation at 37 ° C, the numbers of cells that migrated to the bottom wells were assessed using a Z2 Coulter Counter (Beckman Coulter, Fullerton, Calif., USA). EDTA (10 m M ) was used to detach migrated cells still attached to the membrane before centri-fuging the plates to collect the migrated cells in the bottom chamber. To confirm that all cells had detached, inserts were stained with 1% crystal violet in 2% ethanol to visualize cells. For inhibition studies, neutralizing MCP-1 antibodies (clone 2H5; Biolegend, San Diego, Calif., USA) or Hamster IgG control antibodies (eBioscience, San Diego, Calif., USA) were incubated with AoAFconditioned medium for 30 min prior to plating.
AoAF Proliferation Assays
The ability of Ang II and monocytes to induce AoAF proliferation in vitro was assessed in 2 separate experiments. First, AoAF were plated at 50 ! 10 3 cells per well in 12-well plates and grown in SCGM for 24 h. The medium was replaced with SCM containing 0.25% BSA, 0.2% FBS, and cells stimulated with 1 M Ang II for 16 h. During the final 4 h, 3 H-thymidine (2 Ci/ml) was added. Plates were briefly washed with 2 ml of cold PBS, and then 2 ml of cold 10% TCA were added and incubated at 4 ° C for 2 h. Cells were washed with 95% ethanol and allowed to dry for 1 min. Five hundred microliters of 0.2 N NaOH was added for 2 h to dissolve the cells. Four hundred fifty microliters of lysate was added to 5 ml of scintillation cocktail, mixed, and dark-adapted for at least 2 h before counting in a Geiger counter (Beckman Coulter). In a second similar experiment, AoAF were plated and grown, and the medium was replaced with SCM as described above, but cells were stimulated with 1 M Ang II for 4 days. AoAF were detached in 0.5 ml Accumax and diluted in 9.5 ml of an Isoton II solution for counting with a Z2 Coulter Counter.
In a second series of experiments, AoAF were labeled with 2 M PKH26 (Sigma, St. Louis, Mo., USA) prior to the start of coculture experiments with THP-1 monocytic cells that remained unlabeled. Briefly, AoAF were labeled according to the manufacturer's instructions by resuspending the cells in 1 ml of solution A (used to dilute PKH26); a 4-M solution of PKH26 dye in 1 ml was made in solution B. Solution A was combined with solution B and the cells were incubated for 3 min at room temperature. The final concentration of PKH26 was 2 M . After incubation, cells were washed with PBS 3 times. Coculture experiments were performed at a monocyte-to-fibroblast ratio of 4: 1. Monocytes (500 ! 10 3 ) were added to a culture of 125 ! 10 3 adventitial fibroblasts in 1.5 ml of RPMI medium containing 5% FBS for 5 days. Cells in coculture were detached with 10 m M EDTA/Accumax, centrifuged, and resuspended in PBS containing 0.5% BSA, and they were kept on ice until they were analyzed by flow cytometry to detect the PE signal from PKH26 using a FACSCanto cytometer (BD Biosciences, San Jose, Calif., USA). For overnight storage, cells were resuspended in 0.5% paraformaldehyde-PBS solution, vortexed immediately, and then kept in the dark on a rotating holder at 4 ° C.
Animal Manipulations
All mice were housed in the UTMB Animal Resource Center in accordance with its Institutional Animal Care and Use Committee guidelines, and the use of animals conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. Male C57BL/6J wild-type (WT) and CCR2 -/-mice (obtained as breeding pairs and bred in-house; C57BL/6J background) were purchased from Jackson Laboratory (Bar Harbor, Me., USA); they were maintained on a 12-hour light/ dark cycle and were allowed food and water ad libitum. CCR2-null mice can produce MCP-1 but have cells lacking the ability to respond to this chemokine; therefore, they lack the CCR2+ monocyte-AoAF interaction. For Ang II infusion, anesthetized mice received subcutaneous osmotic minipumps (Alzet, Cupertino, Calif., USA) delivering either saline (sham) or Ang II (synthesized at UTMB) at 2,500 ng/kg/min for 10 days.
Aortic Digestion and Flow Cytometric Quantitation of Fibroblasts
Aortas were removed from anesthetized mice, minced into 3-to 4-mm pieces, and placed in 1-ml digestion solution containing 0.6 units/ml Liberase Blendzyme 3 (Roche) and 50 g/ml porcine pancreatic elastase (Sigma-Aldrich) in a base solution of DMEM. Aortic tissue was digested at 37 ° C with agitation for 1 h. After digestion, cells were washed in FACS buffer (0.5% BSA and 0.02% NaN 3 in DMEM) at 300 g for 5 min and then fixed and permeabilized in fixation/permeabilization solution (eBiosciences) for 30 min at 4 ° C. Murine Fc receptors were blocked using antibodies against mouse CD16/32 antigens (eBioscience) for 10 min on ice. Fluorochrome-conjugated anti-ER-TR7 antibodies (eBioscience) were incubated for 30 min at 4 ° C. Corresponding isotype control antibodies were added to 'isotype samples' at the same concentrations as the antibodies of interest. After incubation, samples were washed 3 times in FACS buffer, centrifuged at 300 g for 5 min, and then fixed in 0.5% PFA and analyzed by FACSCanto. Debris and dead cells, defined by forward scatter, were excluded from analysis. Data were analyzed with FlowJo software.
Monocyte Isolation
Blood was obtained from WT C57BL/6J mice by cardiac puncture and erythrocytes lysed with RBC lysis solution (Invitrogen) added to the blood in a 3: 1 ratio for 5 min at room temperature. Cells were centrifuged at 1,000 g for 3 min to remove the RBC lysis solution, and the leukocyte pellet was resuspended and washed in cell isolation buffer (2% heat-inactivated FBS and 2 m M EDTA in PBS) followed by centrifugation at 400 g for 10 min. Leukocyte counting was done using the Trypan blue exclusion method with a hemocytometer. Negative isolation of monocytes was performed according to the SpinSep Monocyte Isolation Custom Kit's instructions (Stem Cell Technologies, Vancouver, B.C., Canada). Briefly, an antibody cocktail was added to the leukocytes for 15 min at 4 ° C and then washed, and 250 l of SpinSep dense particles were added per 5 ! 10 7 cells. This cell/particle suspension was incubated on ice for 20 min with occasional mixing. The mixture was gently layered over SpinSep density medium and then centrifuged. The enriched cells from the interface were carefully removed and washed, and PBS was added to resuspend the monocytes before injection. Eight mice allowed the isolation of 1.5 ! 10 6 monocytes, representing 7% of all leukocytes. The purity was 1 95% as assessed by staining for CD14. Monocytes from CCR2 -/-mice were obtained similarly.
Adoptive Transfer of Mouse Monocytes
Monocytes (1.5 ! 10 6 ) in 150 l of PBS were injected via the mouse tail vein using a 26-gauge needle; 4 days later, mice were sacrificed and the ascending aorta was embedded and quickly frozen in OCT on dry ice. Six-micrometer cross sections were cut and analyzed using Movat's stain. Micrographs were taken at a magnification of 20 ! with a Nikon Eclipse fluorescence microscope, and the images were collected using ACT-1 software.
Quantitative Real-Time PCR Total cellular RNA was extracted from AoAF using TRI Reagent (Sigma). Validated real-time PCR primers for human IL-6 (forward 5 -GGCACTGGCA GAAAACAACC-3 and reverse 5 -GCAAGTCTCCTCATTGAATCC-3 ) and MCP-1 (forward 5 CATTGTG GCCAAGGAGATCTG-3 and reverse 5 -CTT-CGGAGTTTGGGTTTGCTT-3 ) were obtained from the RT Primer Database (http://medgen.ugent.be/rtprimerdb). Thermal cycling was performed with a BioRad MyIQ5 real-time PCR system (BioRad, Hercules, Calif., USA) under factory defaults. GAPDH mRNA levels were measured for each sample and utilized as the internal control. Fold change values were calculated using the 2 -⌬ ⌬ Ct method with the control sample as the calibrator.
Immunohistochemistry
Slides containing frozen cross sections (6 m) from Ang II-or sham-treated mouse aortas were fixed with 4% PFA for 30 min, blocked with 0.3% H 2 O 2 for 10 min and 0.3% Triton-X and 5% goat serum for 1 h at room temperature, and then incubated with primary anti-fibroblast antibody (1: 200, ER-TR7; Abcam) or anti-PCNA (1: 500; Abcam) at 4 ° C overnight. After washing, secondary antibodies were added at a dilution of 1: 200 for 1 h at room temperature, followed by incubation with avidin-biotin complex for 1 h (Vector ABC kit). 3,3 -Diaminobenzidine (Vector) was applied for 5 min to identify positive immunoreaction. Slides were counterstained with hematoxylin (for fibroblast imaging only), dehydrated in ethanol and xylene, and mounted in Cytoseal (Richard-Allan Scientific).
Data Analysis
Data are reported as the means 8 SD of 3 independent experiments unless otherwise noted. Differences were analyzed by Student's t test (2-tailed, assuming unequal variances), or by a 1-way analysis of variance (ANOVA) followed by a post hoc Tukey pairwise comparison. p ! 0.05 was considered statistically significant.
Results
Cytokine Production by Human AoAF
While there has been growing interest in the role of adventitial fibroblasts in vascular pathology [21] , the spectrum of cytokines produced by these cells has not been well described. Using a multiplex cytokine ELISA assay and SCGM bathing of AoAF for 36 h, we tested the ability of AoAF to secrete constitutively numerous inflammatory cytokines. IL-6 and MCP-1 were detected at the highest concentration relative to all other cytokines which were detected at substantially lower concentrations ( table 1 ) 
Ang II Increased Expression of IL-6 and MCP-1 in AoAF
Since AoAF constitutively produced an abundant amount of IL-6 and MCP-1 protein, we tested the ability of Ang II to induce their expression using quantitative real-time PCR. Ang II induced a rapid increase in IL-6 and MCP-1; IL-6 mRNA was induced 10-fold at 3 h and remained elevated at 4-6-fold up to 48 h, while MCP-1 mRNA was induced 2-fold at 3 h but had returned to baseline by 6 h ( fig. 1 ) . Together, these data indicate an Ang II-induced expression of monokines by AoAF. 
MCP-1 Produced from AoAF-Recruited Monocytes
To ensure that the MCP-1 produced by AoAF was functionally active, we performed cell migration assays using Boyden chambers with AoAF-conditioned medium as the attractant. There was a 3-fold increase in the number of THP-1 cells that migrated toward the conditioned medium compared to the control media ( fig. 2 a) . This effect was blocked dose dependently with an anti-MCP-1 neutralizing antibody (58% at the highest dose used) ( fig. 2 b) . These data indicate that AoAF secrete biologically active monocyte chemoattractant MCP-1.
Ang II Stimulation as well as Coculturing AoAF with Monocytes Enhanced AoAF Proliferation
Ang II had a weak mitogenic effect on human AoAF measured as a slight but statistically significant increase in radiolabeled thymidine incorporation into AoAF ( fig. 3 a) . Ang II exposure for a longer duration (4 days) also produced a slight but significant increase in AoAF numbers ( fig. 3 b) . Since monocytes/macrophages have been shown to be present in the adventitia of diseased vessels, we tested whether monocytes recruited by AoAF could stimulate the proliferation of AoAF. Coculturing AoAF and THP-1 cells led to a small but statistically significant increase in fibroblast cell number as compared to AoAF cultured alone over the same duration ( fig. 4 ) . To exclude potential monocyte contamination of the AoAF counting, we labeled the AoAF with PKH26, a PE dye, prior to flow cytometry ( fig. 4 a) . The dye was not transferred to THP-1 cells ( fig. 4 b) and has been shown to pass only to daughter cells [22] . After coculture with unlabeled monocytes, labeled AoAF were detected as events in M1 ( fig. 4 c) , and a small but significant increase was measured ( fig. 4 d) .
Ang II Stimulated Adventitial Fibrosis in WT Mice
Staining for monocytes and macrophages previously demonstrated that the adventitia was the major site of macrophage recruitment after Ang II infusion in mice [7, 23, 24] . Coincidentally, the adventitia thickened mainly due to an increase in fibroblasts [7, 20] . Immunohistochemical staining with the fibroblast-specific anti-ER-TR7 antibody demonstrated aortic fibroblasts predominantly in the adventitia of control mice but also interspersed throughout the medial vessel wall ( fig. 5 a) . A similar pattern was evident in aortas from mice infused with Ang II for 6 days, with strong staining of the adventitia which also demonstrated enhance cellularity ( fig. 5 b) . PCNA staining was stronger in the adventitia of 6-day Ang II-infused mice versus sham mice, indicating the presence of increased numbers of proliferating cells in Ang II-treated mice ( fig. 5 c, d) .
To quantitate the Ang II-induced stimulation of fibroblast proliferation in vivo, aortas from sham-and Ang II-stimulated mice were digested to obtain single cell preparations, and the fibroblast population was determined with flow cytometry using primary antifibroblast antibody ER-TR7 (Abcam). Figure 6 a shows 2 representative flow cytometry experiments, and the quantitation from 3 experiments in figure 6 b demonstrates that Ang II induced a 3-fold increase in AoAF.
Adoptive Transfer of CCR2 +/+ Monocytes into CCR2-Deficient Mice Restored Adventitial Thickening
Increased fibrosis and expansion of adventitia has been reported to be blunted along with reduced macrophage recruitment to the aorta of CCR2-deficient mice infused with Ang II [25] . Since CCR2 is the receptor for MCP-1, we hypothesized that the recruitment of CCR2 +/+ monocytes and macrophages was a result of increased MCP-1 production by AoAF in response to Ang II, and that the increased monocyte recruitment was required for adventitial fibroblast proliferation leading to adventitial thickening. We performed an adoptive transfer of CCR2 +/+ monocytes at a physiologically relevant number into Ang II-infused CCR2 -/-mice and found that the cellular content (red stain indicating cytoplasm) and thickness of the adventitia dramatically increased in the presence of CCR2 +/+ monocytes ( fig. 7 ) . The increased adventitial thickening was similar to that observed in WT mice after 10 days of infusion. 
Discussion
In this study, we used a combination of tissue culture and multiplex cytokine ELISA assays to demonstrate that AoAF produce and secrete numerous inflammatory cytokines and chemokines of relevance to vascular pathobiology, particularly IL-6 and MCP-1. We also showed that Ang II further upregulates the transcription of IL-6 and MCP-1 in AoAF in vitro, and that MCP-1 is the primary monocyte chemoattractant secreted by AoAF. Our finding that blocking MCP-1 activity with a neutralizing antibody significantly decreased, but did not totally block, monocyte recruitment suggests that additional chemokines produced by AoAF may also influence monocyte recruitment. While we identified numerous cytokines released from AoAF at relatively low concentrations in the tissue culture media, such results do not address their potential potency in vivo. Identifying these additional chemokines should provide a more thorough understanding of how monocytes/macrophages and other leukocytes are recruited into the adventitia. We also reported that THP-1 cells, a human leukemic promonocytic cell line, produced numerous cytokines in response to Ang-II, although their production of IL-6 and MCP-1 was significantly less than the AoAF production of these factors. These cells have been used extensively since they share many properties of primary monocytes, especially in terms of cytokine production and differentiation. Nevertheless, the fact that these cells are cancerous suggests that their production of factors responsible for cell growth and proliferation in vitro may differ significantly from primary monocytes. Previous studies from our laboratory are consistent with the cytokine observations reported here. We have reported IL-6 localization in the aortic wall of sham and Ang II-treated mouse aortas using in situ hybridization, and we have demonstrated a significant Ang II-induced increase in staining in the adventitia of these vessels [7] . In addition, we have measured cytokine production in time course experiments using adventitial explants stripped from the walls of sham-and Ang II-treated aortas, and we have reported significantly more IL-6 cytokine production in the adventitial portion of the vessel wall than in the medial/endothelial layer [7] .
Ang II infusion is a potent inducer of vascular inflammation, and its physiological effect has been extensively studied in mouse models. It is well established that Ang II infusion enhances macrophage recruitment and accelerates atherosclerosis and aneurysm formation [26] [27] [28] , and monocyte chemokines including osteopontin and MCP-1 have been implicated. However, many of these studies have been limited by the inability of histochemistry methods to systematically quantitate regional differences in macrophage number as well as their activation state. Previously, we had adapted methods of aortic tissue dissociation and quantitative flow cytometry to demonstrate that Ang II potently induced monocyte-to-macrophage activation and dramatically increased macrophage numbers in animals with aortic dilatation and dissection [29] . Because AoAF can recruit monocytes, and since macrophages are found in the adventitia of human and rodent atherosclerotic vessels and aortic aneurysms [20, 30, 31] , we had hypothesized that monocytes contribute to fibroblast proliferation. Using CCR2 -/-mice, we demonstrat- ed less adventitial thickening in response to Ang II than in WT mice; using adoptive transfer of CCR2 +/+ monocytes into the CCR2-null mice, we showed that recruitment of CCR2 +/+ monocytes restored the adventitial thickening in response to the mitogenic effect of Ang II. We have previously identified, using the same adoptive transfer of fluorescently labeled monocytes, 2 regional sites within the aorta for the uptake and adventitial accumulation of monocytes that were dependent on Ang II stimulation and CCR2 signaling [29] . In that study, we demonstrated that monocyte recruitment into the aorta potentiated IL-6 production, that it was predominantly localized in the adventitia of our animal model, and that this process was governed by paracrine factors released during monocyte-aortic fibroblast interactions. Although the adventitial thickening in this study may be partly mediated by infiltrating leukocytes, we have previously shown that adventitial fibroblasts comprise most of +/+ monocytes into sham-treated (n = 5) or Ang II-treated (n = 6) CCR2 -/-mice via the tail vein was performed on day 6 of the Ang II infusion and the animals were sacrificed 4 days later. Cell/cytoplasm is red, collagen is yellow, elastin is black, and mucopolysaccharide is blue. Microphotographs of 6-m-thick aortic cross sections were taken at a magnification of 20 ! . Scale bar = 100 m. the thickened adventitia in response to Ang II infusion in mice [7] . That observation, based on immunofluorescent staining of adventitial fibroblasts, was confirmed here as well. In this study, using quantitative flow cytometry on single cell preparations from enzymatically digested aortic tissue, we demonstrate that Ang II significantly increased the number of recoverable fibroblasts from the vessel wall. In addition, we showed increased PCNA staining of the adventitia from Ang II-treated versus control aortas. While the latter observation correlates with increased fibroblast staining, we have not definitively shown that the increased PCNA staining is within the proliferating fibroblasts. In addition, our studies do not preclude the possibility of fibroblast migration contributing to the increased numbers of adventitial fibroblasts. Nevertheless, taken together, we have provided strong documentation of Ang II-induced increases in adventitial fibroblast proliferation. While we have not yet identified how monocytes induce further AoAF proliferation, several secreted cytokines from monocytes are known to induce proliferation, including IL-1, TNF, p43, and substances similar to PDGF [32, 33] . Interestingly, we showed that IL-1 and TNF are secreted by THP-1 monocytes in tissue culture at greater levels than adventitial fibroblasts ( table 1 ) .
In conclusion, our data strongly indicate that aortic adventitial fibroblasts are key mediators of vascular wall inflammation. These cells respond to Ang II stimulation by proliferating and producing cytokines and chemokines that can recruit monocytes and other leukocytes such as T and B lymphocytes. The monocyte-adventitial fibroblast interaction further increases AoAF cell proliferation, leading to further cytokine production, leukocyte recruitment, and expansion of the adventitia, 3 hallmarks of adventitial inflammation seen in cardiovascular diseases such as inflammatory aortic aneurysm and advanced atherosclerosis. This series of events may contribute significantly to the pathophysiology of the aortic wall which leads to an increased risk of plaque rupture in atherosclerotic vessels with extensive adventitial inflammation.
